Scott Brodeur, PhD, Program Director, Crohn’s Disease
NEW YORK, January 20, 2026 — The Leona M. and Harry B. Helmsley Charitable Trust (“Helmsley”) today announced that Scott Brodeur, PhD, has been hired as Program Director for Helmsley’s Crohn’s Disease Program.
With over 20 years of experience in the pharmaceutical and biotechnology industries, Dr. Brodeur is a trained immunologist, a leader in therapeutics development, and an expert in autoimmunity and inflammation. Dr. Brodeur was most recently the Executive Director of Discovery Pharmacology at Third Arc Bio. He previously served as Senior Director of Exploratory Biology at J&J Innovative Medicines, as Principal Scientist at Bristol-Myers Squibb, and as Senior Principal Scientist at Boehringer Ingelheim Pharmaceuticals.
“Bringing Scott on as Program Director represents an exciting new chapter for the Crohn’s Disease program at Helmsley,” said Sandor Frankel, Trustee at the Helmsley Charitable Trust. “His deep scientific expertise and strong record of managing high-performing teams will elevate our work and deepen the impact we make as we strive to find a cure for Crohn’s Disease and to help patients’ lives until we succeed.”
Helmsley is the largest private philanthropy focused on Crohn’s disease, a complex, chronic inflammatory bowel disease that affects more than 2 million people worldwide. The Crohn’s Disease Program is committed to finding cures, and until then, to improving the quality of life and care for people with Crohn’s disease. Based at Helmsley’s New York office, the program focuses on funding in five key and interrelated areas: prevention, disease management, therapeutics, diagnostics, and disease biology. Since the program began in 2009, it has awarded grants totaling more than $650 million to support the work of scientists and clinicians worldwide.
As Program Director, Dr. Brodeur will lead the Crohn’s program staff in sourcing, designing, evaluating, and executing grant projects and related program-related grants.
“Over the years, the Helmsley Charitable Trust has been a leader in supporting innovative Crohn’s disease research. The organization takes a thoughtful approach to identifying initiatives that drive the mission of finding a cure while simultaneously improving the lives of those afflicted by the disease,” said Dr. Brodeur. “I’m looking forward to being a part of Helmsley’s impactful work.”
###
About the Helmsley Charitable Trust
The Leona M. and Harry B. Helmsley Charitable Trust aspires to improve lives by supporting exceptional efforts in the U.S. and around the world in health and select place-based initiatives. Since beginning active grantmaking in 2008, Helmsley has awarded more than $4.6 billion for a wide range of charitable purposes. For more information on Helmsley and its programs, visit helmsleytrust.org.
###
Media Contact
Erin Callanan
646-618-3515
